pharmacie et médicaments – Médicaments innovants contre le myélome multiple

This written question concerns access to innovative medicines for treating multiple myeloma, a type of blood cancer. It highlights the importance of timely access to new treatments for patients. The question likely seeks information on the availability and pricing of these advanced drugs, potentially affecting patients, healthcare providers, and pharmaceutical companies.